| scholarly article | Q13442814 |
| P50 | author | Deborah Zarin | Q20715644 |
| Harlan M. Krumholz | Q28211478 | ||
| Joseph S. Ross | Q42409824 | ||
| Tony Tse | Q58077300 | ||
| P2093 | author name string | Lei Zhou | |
| Hui Xu | |||
| P2860 | cites work | Publication of clinical trials supporting successful new drug applications: a literature analysis | Q21563410 |
| Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 | ||
| Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov | Q24289273 | ||
| Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research | Q28285027 | ||
| Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation | Q28474127 | ||
| Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis | Q28476002 | ||
| Publication bias in clinical research | Q29541186 | ||
| Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles | Q29618882 | ||
| Systematic review of the empirical evidence of study publication bias and outcome reporting bias | Q29619094 | ||
| Fate of biomedical research protocols and publication bias in France: retrospective cohort study | Q33217505 | ||
| Trial Registration at ClinicalTrials.gov between May and October 2005 | Q33230454 | ||
| The ClinicalTrials.gov Results Database — Update and Key Issues | Q33834724 | ||
| Testing for the presence of positive-outcome bias in peer review: a randomized controlled trial | Q34024803 | ||
| NIH clinical trials and publication bias | Q34349425 | ||
| Bias in reporting clinical trials | Q35802548 | ||
| Publication bias: evidence of delayed publication in a cohort study of clinical research projects | Q36246225 | ||
| Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards | Q36728722 | ||
| Comparative effectiveness research: who will do the studies? | Q38426665 | ||
| State of the Controlled Clinical Trial Enterprise in the United States | Q39800619 | ||
| Factors associated with failure to publish large randomized trials presented at an oncology meeting | Q44014171 | ||
| Publication bias and research on passive smoking: comparison of published and unpublished studies. | Q46034623 | ||
| Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee | Q46059332 | ||
| Clinical trial registration: a statement from the International Committee of Medical Journal Editors. | Q55038991 | ||
| Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials | Q74121809 | ||
| P433 | issue | jan03 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ClinicalTrials.gov | Q5133746 |
| P304 | page(s) | d7292 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis | |
| P478 | volume | 344 |
| Q55096677 | A Review of Ginseng Clinical Trials Registered in the WHO International Clinical Trials Registry Platform. |
| Q38742622 | A Review of Skull Base Tumor Clinical Trials: Past Trends and Future Opportunities |
| Q42342410 | A historic moment for open science: the Yale University Open Data Access project and medtronic |
| Q34337449 | A snapshot and scorecard for analgesic clinical trials for chronic pain: The RReACT database |
| Q33864361 | A systematic review of the processes used to link clinical trial registrations to their published results |
| Q38120856 | A two-step manuscript submission process can reduce publication bias |
| Q41740967 | Aggregator: a machine learning approach to identifying MEDLINE articles that derive from the same underlying clinical trial |
| Q35844346 | Analysis of 473 US Head and Neck Cancer Trials (1996-2014): Trends, Gaps, and Opportunities |
| Q30986403 | Assessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES. |
| Q43698800 | Availability of results from clinical research: failing policy efforts. |
| Q38369293 | Barriers to the conduct of randomised clinical trials within all disease areas. |
| Q85902502 | Biomarkers, Putative Surrogates, Surrogates, and Decision Making |
| Q37638488 | Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov |
| Q40054181 | Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015. |
| Q38623810 | Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration. |
| Q37022012 | Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov |
| Q36989694 | Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis |
| Q28595531 | Clinical research data sharing: what an open science world means for researchers involved in evidence synthesis |
| Q55190272 | Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005. |
| Q53282847 | Clinical trial registration and reporting: a survey of academic organizations in the United States |
| Q89823454 | Clinical trial registration, and publication in acupuncture studies: A systematic review |
| Q26777323 | Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012 |
| Q43078326 | Clinical trial results: Sharing results, speeding discoveries |
| Q47174976 | Clinical trials in rhinosinusitis: Identifying areas for improvement |
| Q34441631 | Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis |
| Q33606537 | Common metrics to assess the efficiency of clinical research |
| Q52592570 | Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis |
| Q45951344 | Comparison of published and unpublished phase I clinical cancer trials: an analysis of the CliniclTrials.gov database. |
| Q24658631 | Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency |
| Q85298598 | Credit for clinical trial data |
| Q30731729 | Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke |
| Q37133927 | Cross-sectional study of Pfizer-sponsored clinical trials: assessment of time to publication and publication history. |
| Q37555973 | Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov |
| Q30491337 | Data Access and Sharing: Are we being transparent about clinical research? Let's do what's right for patients |
| Q29994551 | Data sharing: A viable resource for future |
| Q60105293 | Delays in the Publication of Important Clinical Trial Findings in Oncology |
| Q36225313 | Developing Common Metrics for the Clinical and Translational Science Awards (CTSAs): Lessons Learned |
| Q34452911 | Discontinuation and non-publication of surgical randomised controlled trials: observational study |
| Q42650121 | Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis |
| Q26783972 | Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials |
| Q58817760 | Effectiveness and safety of insulin glargine detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis |
| Q38817527 | Efficient design of clinical trials and epidemiological research: is it possible? |
| Q30543230 | Epilepsy therapy development: technical and methodologic issues in studies with animal models |
| Q38901359 | Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease |
| Q24288672 | Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries |
| Q43098246 | Factorial clinical trials: a new approach to phase II neuro-oncology studies |
| Q90098854 | Factors associated with the successful completion of randomized controlled trials in gynecological oncology |
| Q58595807 | Fate of abstracts presented at the Turkish Association of Oral and Maxillofacial Surgeons (TAOMS) meetings between 2007 and 2009 |
| Q46354967 | Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials |
| Q87135072 | Finishing the Picture: Problems With Public Reporting of Clinical Trials |
| Q90717949 | From registration to publication: A study on Dutch academic randomized controlled trials |
| Q90145898 | Going Beyond "Not Enough Time": Barriers to Preparing Manuscripts for Academic Medical Journals |
| Q28485060 | Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational |
| Q34323547 | Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications–a cross-sectional study |
| Q38827753 | Health research participants' preferences for receiving research results |
| Q33903992 | How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database |
| Q36205488 | How often do US-based human subjects research studies register on time, and how often do they post their results? A statistical analysis of the Clinicaltrials.gov database |
| Q55009838 | How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider. |
| Q30932208 | How to get all trials reported: audit, better data, and individual accountability |
| Q34303798 | How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT). |
| Q34211759 | Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial |
| Q26995526 | Inadequate use and regulation of interventions against publication bias decreases their effectiveness: a systematic review |
| Q84455776 | Increasing Need for Academic Leadership in Clinical Trials |
| Q48216988 | Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review |
| Q92414184 | Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism |
| Q36790524 | Italian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases. |
| Q21559603 | Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials |
| Q53195575 | Linking quality indicators to clinical trials: an automated approach |
| Q52562536 | Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia: A cross-sectional analysis. |
| Q46177929 | Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. |
| Q44267078 | Mind the gap: efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics |
| Q48094320 | Modelling science trustworthiness under publish or perish pressure |
| Q28660290 | Moving forward from rhBMP-2: open science and data sharing |
| Q45018512 | Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help! |
| Q37440674 | Network meta-analyses performed by contracting companies and commissioned by industry |
| Q37266348 | Non-publication of large randomized clinical trials: cross sectional analysis. |
| Q61444700 | Nonpublication Rates and Characteristics of Registered Randomized Clinical Trials in Digital Health: Cross-Sectional Analysis |
| Q104501831 | Obstacles to the reuse of study metadata in ClinicalTrials.gov |
| Q37236087 | On-the-Job Evidence-Based Medicine Training for Clinician-Scientists of the Next Generation |
| Q52694302 | Patient and public involvement in reducing health and care research waste. |
| Q53283381 | Patient consent to publication and data sharing in industry and NIH-funded clinical trials |
| Q34430726 | Peer review of grant applications: criteria used and qualitative study of reviewer practices |
| Q50001044 | Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study. |
| Q55277805 | Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. |
| Q31115101 | Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide |
| Q93360917 | Principles of designing a clinical trial: optimizing chances of trial success |
| Q33694159 | Processes to manage analyses and publications in a phase III multicenter randomized clinical trial |
| Q35906626 | Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov |
| Q38108574 | Publication Bias, with a Focus on Psychiatry: Causes and Solutions |
| Q88516474 | Publication and Dissemination of Results in Clinical Trials of Neurology |
| Q30360244 | Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. |
| Q38017182 | Publication of Sports Medicine–Related Randomized Controlled Trials Registered in ClinicalTrials.gov |
| Q42368655 | Publication of interventional phase 3 and 4 clinical trials in radiation oncology: an observational study |
| Q37592322 | Publication of trials funded by the National Heart, Lung, and Blood Institute |
| Q49773294 | Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials.gov results database |
| Q36821779 | Publication rate for funded studies from a major UK health research funder: a cohort study. |
| Q90454879 | Quality and Publication of Emergency Medicine Trials Registered in |
| Q41255731 | Randomized clinical trials in orthodontics are rarely registered a priori and often published late or not at all. |
| Q48226590 | Randomized controlled trials of rheumatoid arthritis registered at ClinicalTrials.gov: what gets published and when |
| Q36361335 | Recruitment and retention in obesity prevention and treatment trials targeting minority or low-income children: a review of the clinical trials registration database |
| Q57455980 | Registration of published randomized trials: a systematic review and meta-analysis |
| Q57800224 | Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study |
| Q35983635 | Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health Interventions |
| Q35649070 | Reporting results of research involving human subjects: an ethical obligation. |
| Q33659105 | Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications. |
| Q43123055 | Restoring the integrity of the clinical trial evidence base |
| Q88034853 | Results Reporting for Trials With the Same Sponsor, Drug, and Condition in ClinicalTrials.gov and Peer-Reviewed Publications |
| Q28728487 | Results and Outcome Reporting In ClinicalTrials.gov, What Makes it Happen? |
| Q34790930 | Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases |
| Q92151698 | Rights to social determinants of flourishing? A paradigm for disability and public health research and policy |
| Q39633187 | SAMURAI: Sensitivity analysis of a meta-analysis with unpublished but registered analytical investigations (software). |
| Q28710019 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials |
| Q46195514 | Scientific non-publishing: the addressed, the unaddressed and the unexplored |
| Q28656418 | Sea change in open science and data sharing: leadership by industry |
| Q35716074 | Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports |
| Q21146606 | Sharing big biomedical data |
| Q35893083 | Should preclinical studies be registered? |
| Q21398203 | Sizing the Problem of Improving Discovery and Access to NIH-Funded Data: A Preliminary Study |
| Q52659602 | Standards for design and measurement would make clinical research reproducible and usable |
| Q34455501 | Surgical trials and trial registers: a cross-sectional study of randomized controlled trials published in journals requiring trial registration in the author instructions |
| Q37356008 | Systematic review protocol assessing the processes for linking clinical trial registries and their published results |
| Q35886881 | Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis |
| Q42545510 | Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. |
| Q30958675 | Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination |
| Q34461507 | The Malaria in Pregnancy Library: a bibliometric review. |
| Q38952676 | The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses |
| Q35754731 | The NIMH experimental medicine initiative |
| Q38560675 | The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency |
| Q28730765 | The importance of clinical trial data sharing: toward more open science |
| Q42598698 | The policy on sharing data |
| Q38117029 | Time to finger point or fix? An invitation to join ongoing efforts to promote ethical authorship and other good publication practices |
| Q36953174 | Time to publication among completed clinical trials |
| Q37352846 | Time to publication for NIHR HTA programme-funded research: a cohort study. |
| Q37728440 | Time to publication for publicly funded clinical trials in Australia: an observational study |
| Q41886616 | Time to publication of oncology trials and why some trials are never published. |
| Q38126350 | Transparent Reporting of Trials Is Essential |
| Q28606883 | Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013 |
| Q91768502 | Trial registration, publication rate and characteristics in the research field of otology: A cross-sectional study |
| Q33551360 | Trial watch: global migration of clinical trials |
| Q44271031 | Use of ClinicalTrials.gov to Estimate Condition-Specific Nocebo Effects and Other Factors Affecting Outcomes of Analgesic Trials |
| Q64287567 | What happens to intimate partner violence studies registered on clinicaltrials.gov? A systematic review of a clinical trials registry |
| Q91866375 | Write-up and dissemination of undergraduate and postgraduate research at the University of Rwanda: a cross-sectional study |
Search more.